NCT04746430View on ClinicalTrials.gov

COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study

PHASE4TerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

February 16, 2021

Primary Completion Date

April 23, 2021

Study Completion Date

April 23, 2021

Conditions
Covid19Corona Virus Infection
Interventions
DRUG

Dexamethasone

6 mg dexamethasone prescribed during ten days and as a precaution combined with electronic monitoring of saturation and other signs and symptoms

Trial Locations (1)

Unknown

GPRI, Groningen

Sponsors
All Listed Sponsors
collaborator

Huisartsenzorg Drenthe

UNKNOWN

lead

General Practitioners Research Institute

NETWORK

NCT04746430 - COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study | Biotech Hunter | Biotech Hunter